Emerging Applications of EpCAM-Targeted Nuclear Medicine Probes: Current Research and Future Perspectives
Authors:
Open Access
- 1 September 2025
- journal article
- review article
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 20, 10815-10830
Abstract
Molecular imaging in nuclear medicine has been employed extensively in recent years for tumor-targeted diagnosis and treatment that is attributed to its non-invasive property, which enables visualized functional localization. This functionality relies on the development of radionuclide molecular probes designed with the objective of identifying specific targets on the surface of tumors. Epithelial cell adhesion molecules (EpCAM) are considered to be a promising target as an antigenic marker for its widely present and integral to the processes associated with tumor occurrence and progression. This paper provides a comprehensive review of recent advancements in EpCAM-targeted radionuclide probes, focusing specifically on a range of primary ligands, including DARPins (Designed Ankyrin Repeat Proteins), antibodies, and aptamers, and evaluates the benefits and challenges, potential future directions of these radioactive probes.Keywords
This publication has 122 references indexed in Scilit:
- Preclinical evaluation of [99mTc]Tc-labeled anti-EpCAM nanobody for EpCAM receptor expression imaging by immuno-SPECT/CTEuropean Journal of Nuclear Medicine and Molecular Imaging, 2022
- Laboratory, Clinical, and Survival Outcomes Associated With Peptide Receptor Radionuclide Therapy in Patients With Gastroenteropancreatic Neuroendocrine TumorsJAMA Network Open, 2021
- The role of radiological and hybrid imaging for muscle metastases: a systematic reviewEuropean Radiology, 2019
- Clinical translation of theranostic radiopharmaceuticals: Current regulatory status and recent examplesJournal of Labelled Compounds and Radiopharmaceuticals, 2019
- Imaging prostate cancer lymph node metastases with a multimodality contrast agentThe Prostate, 2011
- 68Ga-labelled recombinant antibody variants for immuno-PET imaging of solid tumoursEuropean Journal of Nuclear Medicine and Molecular Imaging, 2010
- The biology of the 17–1A antigen (Ep-CAM)Journal of Molecular Medicine, 1999
- Human TROP-2 is a tumor-associated calcium signal transducerInternational Journal of Cancer, 1998
- The mathematics of SELEX against complex targetsJournal of Molecular Biology, 1998
- Biochemical and immunological characterization of the human carcinoma‐associated antigen MH 99/KS 1/4International Journal of Cancer, 1993